TY - JOUR
T1 - Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty
T2 - A Multifactorial Score
AU - Cruz-Gonzalez, Ignacio
AU - Sanchez-Ledesma, Maria
AU - Sanchez, Pedro L.
AU - Martin-Moreiras, Javier
AU - Jneid, Hani
AU - Rengifo-Moreno, Pablo
AU - Inglessis-Azuaje, Ignacio
AU - Maree, Andrew O.
AU - Palacios, Igor F.
N1 - Funding Information:
Funding: Dr Cruz-Gonzalez acknowledges the support and funding of the Spanish Society of Cardiology (Hemodynamic section) and Medtronic Iberia S.A. Drs Cruz-Gonzalez and Sanchez-Ledesma acknowledge the support of the University Hospital of Salamanca.
Funding Information:
We thank the research assistants and staff of the Knight Center Cardiac Catheterization Laboratory at Massachusetts General Hospital for assistance with data collection. We also acknowledge the statistical assistance of E. Halpern, PhD, chief statistician of the Institute for Technology Assessment, Massachusetts General Hospital. We also acknowledge the support of the Cardiovascular Network RECAVA, Instituto Carlos III, Spanish Ministry of Health.
PY - 2009/6
Y1 - 2009/6
N2 - Background: Percutaneous mitral valvuloplasty (PMV) success depends on appropriate patient selection. A multifactorial score derived from clinical, anatomic/echocardiographic, and hemodynamic variables would predict procedural success and clinical outcome. Methods: Demographic data, echocardiographic parameters (including echocardiographic score), and procedure-related variables were recorded in 1085 consecutive PMVs. Long-term clinical follow-up (death, mitral valve replacement, redo PMV) was performed. Multivariate regression analysis of the first 800 procedures was performed to identify independent predictors of procedural success. Significant variables were formulated into a risk score and validated prospectively. Results: Six independent predictors of PMV success were identified: age less than 55 years, New York Heart Association classes I and II, pre-PMV mitral area of 1 cm2 or greater, pre-PMV mitral regurgitation grade less than 2, echocardiographic score of 8 or greater, and male sex. A score was constructed from the arithmetic sum of variables present per patient. Procedural success rates increased incrementally with increasing score (0% for 0/6, 39.7% for 1/6, 54.4% for 2/6, 77.3% for 3/6, 85.7% for 4/6, 95% for 5/6, and 100% for 6/6; P < .001). In a validation cohort (n = 285 procedures), the multifactorial score remained a significant predictor of PMV success (P < .001). Comparison between the new score and the echocardiographic score confirmed that the new index was more sensitive and specific (P < .001). This new score also predicts long-term outcomes (P < .001). Conclusion: Clinical, anatomic, and hemodynamic variables predict PMV success and clinical outcome and may be formulated in a scoring system that would help to identify the best candidates for PMV.
AB - Background: Percutaneous mitral valvuloplasty (PMV) success depends on appropriate patient selection. A multifactorial score derived from clinical, anatomic/echocardiographic, and hemodynamic variables would predict procedural success and clinical outcome. Methods: Demographic data, echocardiographic parameters (including echocardiographic score), and procedure-related variables were recorded in 1085 consecutive PMVs. Long-term clinical follow-up (death, mitral valve replacement, redo PMV) was performed. Multivariate regression analysis of the first 800 procedures was performed to identify independent predictors of procedural success. Significant variables were formulated into a risk score and validated prospectively. Results: Six independent predictors of PMV success were identified: age less than 55 years, New York Heart Association classes I and II, pre-PMV mitral area of 1 cm2 or greater, pre-PMV mitral regurgitation grade less than 2, echocardiographic score of 8 or greater, and male sex. A score was constructed from the arithmetic sum of variables present per patient. Procedural success rates increased incrementally with increasing score (0% for 0/6, 39.7% for 1/6, 54.4% for 2/6, 77.3% for 3/6, 85.7% for 4/6, 95% for 5/6, and 100% for 6/6; P < .001). In a validation cohort (n = 285 procedures), the multifactorial score remained a significant predictor of PMV success (P < .001). Comparison between the new score and the echocardiographic score confirmed that the new index was more sensitive and specific (P < .001). This new score also predicts long-term outcomes (P < .001). Conclusion: Clinical, anatomic, and hemodynamic variables predict PMV success and clinical outcome and may be formulated in a scoring system that would help to identify the best candidates for PMV.
KW - Percutaneous mitral valvuloplasty
KW - Prognosis
KW - Score
UR - http://www.scopus.com/inward/record.url?scp=66149172347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66149172347&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2008.10.038
DO - 10.1016/j.amjmed.2008.10.038
M3 - Article
C2 - 19486721
AN - SCOPUS:66149172347
SN - 0002-9343
VL - 122
SP - 581.e11-581.e19
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 6
ER -